Sperling M A
Pediatr Clin North Am. 1984 Jun;31(3):591-610. doi: 10.1016/s0031-3955(16)34608-9.
In the past decade, considerable advances have occurred in our understanding of the pathophysiology of this disorder, its metabolic sequelae, and its management, particularly with respect to continuous low-dose insulin infusion and the potential benefits of phosphate. This article reviews these advances as they pertain to children.
